Immunovant, Inc. (NASDAQ:IMVT) appears in 213 institutional 13F filings for the quarter ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 16,947,888 | -42,866 | -0.25% | $420,985,547.00 |
| Deep Track Capital, LP | 31 Mar, 2026 | 11,526,971 | 0 | 0.00% | $286,329,960.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 6,574,497 | 516,281 | 8.52% | $163,310,512.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 5,457,881 | 0 | 0.00% | $135,573,764.00 |
| State Street Corp | 31 Mar, 2026 | 4,537,929 | 751,003 | 19.83% | $112,722,156.00 |
| TCG Crossover Management, LLC | 31 Mar, 2026 | 4,457,988 | 2,797,055 | 168.40% | $110,736,422.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,876,877 | -969,508 | -20.00% | $96,301,649.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 3,704,905 | 3,704,905 | 0.00% | $92,029,840.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,620,050 | 3,620,050 | 0.00% | $89,922,042.00 |
| T. Rowe Price Investment Management, Inc. | 31 Mar, 2026 | 3,612,860 | -2,021,002 | -35.87% | $89,744.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 3,564,916 | -2,182,239 | -37.97% | $88,552,513.00 |
| Two Seas Capital LP | 31 Mar, 2026 | 3,201,962 | 335,000 | 11.68% | $79,536,736.00 |
| JENNISON ASSOCIATES LLC | 31 Mar, 2026 | 3,196,705 | 2,496,241 | 356.37% | $79,406,150.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 3,177,849 | -1 | 0.00% | $78,937,769.00 |
| ADAR1 Capital Management, LLC | 31 Mar, 2026 | 2,679,010 | -2,282,926 | -46.01% | $66,546,608.00 |
| Alpine Global Management, LLC | 31 Mar, 2026 | 2,636,925 | -2,617,459 | -49.81% | $65,501,217.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,092,102 | 234,570 | 12.63% | $51,977,423.00 |
| Woodline Partners LP | 31 Mar, 2026 | 1,975,869 | 0 | 0.00% | $49,080,586.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,785,107 | -806,909 | -31.13% | $44,342,057.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 1,597,383 | -397,507 | -19.93% | $39,678,994.00 |